CIK 0001690585
- Non-accelerated filer
- Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,043,610
- in 4 filings, $16.0M under 10b5-1 plans
Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Romano Steven J. Director | Grant or award · Stock Option (Right to Buy) | +6,090 | 6,090 | ||
| 2025-05-22 | Romano Steven J. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-09-16 | Romano Steven J. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 1 of 1 · 3 trades